Fig. 6From: Mass cytometric analysis of the immune cell landscape after traumatic brain injury elucidates the role of complement and complement receptors in neurologic outcomesC5aR1 antagonist PMX205 reduces immune cell recruitment to injured hemisphere but has no impact on neurological outcomes following TBI. A Summary of C5aR1 expression by the 13 immune cell types identified by CyTOF. Non-significant changes (compared to the sham group) are in gray. B Graphical summary of the PMX205 experiment. Injured groups received PBS or PMX205. Sham (control) group was included. C Total number of CD45high cells (immune cells) extracted from the injured brain hemispheres in cohort 1 and quantified by flow cytometry. N = 9–10 per group. D–I Summary of the behavioral outcomes and lesion volume over 28 days after TBI. N = 8–10 per group. C–I Data are shown as mean ± SEM. *p < 0.05. False discovery rate was used to adjust the p-value in panel A. Repeated measures ANOVA was used in panel D. Bonferroni correction was used for multiple comparisons in the panels. Abbreviations: cDC = conventional dendritic cell, pDC = plasmacytoid dendritic cell, MdC = monocyte-derived cellBack to article page